Ultomiris 1100 mg (Ravulizumab SOLUTION) 1100 MG

Ultomiris 1100 mg is a solution for intravenous administration, containing ravulizumab. This medication is used to manage certain medical conditions. Learn more about its uses and effects.

Strength

1100 MG

Manufacturer / TM Owner

ALEXION PHARMA GMBH

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ultomiris 1100 mg is primarily used for the treatment of conditions related to complement-mediated disorders. Ravulizumab, the active ingredient, is designed to target specific proteins in the body to help manage these conditions. Patients often wonder, 'What is Ultomiris used for?' It is typically prescribed for conditions where the immune system is overactive, leading to damage in the body.

Side Effects

Common effects of Ultomiris 1100 mg may include reactions at the injection site, such as redness or swelling. Some patients may experience fatigue or headaches. These effects vary among individuals and are not exhaustive. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Ultomiris 1100 mg should be handled with care. It is important to follow the storage instructions provided to maintain its efficacy. Patients with certain medical conditions or allergies should inform their healthcare provider before use. Proper administration by a healthcare professional is crucial.

Avoid Interactions

Ultomiris 1100 mg may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods may also affect how this medication works.

Frequently Asked Questions

Ultomiris 1100 mg is used to manage conditions related to complement-mediated disorders, where the immune system is overactive.

Ultomiris 1100 mg is administered intravenously by a healthcare professional.

Common effects may include reactions at the injection site, fatigue, and headaches.

It is important to discuss all current medications with a healthcare provider to avoid potential interactions.

Follow storage instructions carefully and inform your healthcare provider of any allergies or medical conditions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.